A new study has found that the sleep drug Ambien is safe to use long term.
The study -- released Wednesday at the Collegium Internationale Neuro-Psychopharmacologicum 25th Biennial Congress in Chicago -- showed Ambien Controlled-Release is "well-tolerated and effective in improving sleep onset and maintenance for up to six months in patients with chronic primary insomnia when taken as needed for up to seven nights per week," Ambien maker Sanofi-Aventis said in a statement.
The data also showed patients in the study had no "rebound insomnia" following discontinuation of the drug. The company said it studied Ambien CR in 1,018 adults for 25 weeks.
"These data are important for patients who experience chronic insomnia because they demonstrate there is a treatment option in Ambien CR that can be taken safely and effectively as needed long-term to help them both fall asleep and maintain sleep through the night," Tom Roth, director of the Sleep Disorders Center at Henry Ford Hospital in Detroit, said in a statement issued by the company.
Leave a comment